Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Pain Management Following Superficial Parotidectomy
NCT06505187Phase 2Recruiting
- Sponsor
- University of Wisconsin–Madison
- Start
- Feb 2025
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in postoperative pain, sponsored by University of Wisconsin–Madison. Started Feb 2025; status: recruiting.
02
Drugs
celecoxib oral solution
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06505187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06505187.